These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 15367050
1. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. Berle JØ, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O. J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050 [Abstract] [Full Text] [Related]
2. [The transfer of selective serotonin reuptake inhibitors to human milk]. Nordeng H, Bergsholm YK, Bøhler E, Spigset O. Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):199-203. PubMed ID: 11475200 [Abstract] [Full Text] [Related]
3. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Epperson CN, Jatlow PI, Czarkowski K, Anderson GM. Pediatrics; 2003 Nov 20; 112(5):e425. PubMed ID: 14595087 [Abstract] [Full Text] [Related]
4. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. Misri S, Kim J, Riggs KW, Kostaras X. J Clin Psychiatry; 2000 Nov 20; 61(11):828-32. PubMed ID: 11105735 [Abstract] [Full Text] [Related]
5. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM. Am J Psychiatry; 2001 Oct 20; 158(10):1631-7. PubMed ID: 11578995 [Abstract] [Full Text] [Related]
6. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL. Am J Psychiatry; 2004 Jun 20; 161(6):1066-78. PubMed ID: 15169695 [Abstract] [Full Text] [Related]
7. Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans. Kuhn UD, Kirsch M, Merkel U, Eberhardt AM, Wenda B, Maurer I, Härtter S, Hiemke C, Volz HP, Balogh A. Int J Clin Pharmacol Ther; 2007 Jan 20; 45(1):36-46. PubMed ID: 17256449 [Abstract] [Full Text] [Related]
8. Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine. Uguz F. Breastfeed Med; 2018 Jan 20; 13(1):89-90. PubMed ID: 29185803 [Abstract] [Full Text] [Related]
9. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital. Uguz F, Arpaci N. Breastfeed Med; 2016 Nov 20; 11():487-489. PubMed ID: 27575664 [Abstract] [Full Text] [Related]
10. Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. Ricardo-Silgado ML, Singh S, Cifuentes L, Decker PA, Gonzalez-Izundegui D, Moyer AM, Hurtado MD, Camilleri M, Bielinski SJ, Acosta A. BMC Med; 2022 Jul 26; 20(1):261. PubMed ID: 35879764 [Abstract] [Full Text] [Related]
11. Excretion of paroxetine into breast milk. Ohman R, Hägg S, Carleborg L, Spigset O. J Clin Psychiatry; 1999 Aug 26; 60(8):519-23. PubMed ID: 10485633 [Abstract] [Full Text] [Related]
12. Antidepressant medication use during breastfeeding. Lanza di Scalea T, Wisner KL. Clin Obstet Gynecol; 2009 Sep 26; 52(3):483-97. PubMed ID: 19661763 [Abstract] [Full Text] [Related]
13. Use of sertraline, paroxetine and fluvoxamine by nursing women. Hendrick V, Fukuchi A, Altshuler L, Widawski M, Wertheimer A, Brunhuber MV. Br J Psychiatry; 2001 Aug 26; 179():163-6. PubMed ID: 11483479 [Abstract] [Full Text] [Related]
14. Antidepressants in breast milk; comparative analysis of excretion ratios. Schoretsanitis G, Augustin M, Saßmannshausen H, Franz C, Gründer G, Paulzen M. Arch Womens Ment Health; 2019 Jun 26; 22(3):383-390. PubMed ID: 30116895 [Abstract] [Full Text] [Related]
15. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. Koren G, Ornoy A. Pharmacogenomics; 2018 Sep 01; 19(14):1139-1145. PubMed ID: 30105921 [Abstract] [Full Text] [Related]
16. Sertraline and desmethylsertraline in human breast milk and nursing infants. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A, Nemeroff CB. Am J Psychiatry; 1997 Sep 01; 154(9):1255-60. PubMed ID: 9286185 [Abstract] [Full Text] [Related]
17. Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system. Ozminkowski RJ, Hylan TR, Melfi CA, Meneades LM, Crown WH, Croghan TW, Robinson RL. Clin Ther; 1998 Sep 01; 20(4):780-96. PubMed ID: 9737837 [Abstract] [Full Text] [Related]
18. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Ball SE, Ahern D, Scatina J, Kao J. Br J Clin Pharmacol; 1997 Jun 01; 43(6):619-26. PubMed ID: 9205822 [Abstract] [Full Text] [Related]
19. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. de Leon J, Susce MT, Murray-Carmichael E. Mol Diagn Ther; 2006 Jun 01; 10(3):135-51. PubMed ID: 16771600 [Abstract] [Full Text] [Related]
20. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, Nemeroff CB. J Clin Psychiatry; 2003 Jan 01; 64(1):73-80. PubMed ID: 12590627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]